Solas Capital Management LLC Purchases New Position in MAIA Biotechnology, Inc. $MAIA
Solas Capital Management LLC purchased a new position in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,030,845 shares of the company’s stock, valued at approximately $4,364,000. MAIA Biotechnology accounts for about 2.3% […]
25 Aug 10:47 · The Markets Daily